Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shozo Nishida

Showing results (111-120 of 126) with videos related to

Pageof 13
Sort By:
Anticancer Research|April 9, 2013
Establishment of a novel model of peritoneal carcinomatosis of the peritoneal extension typeMotohiro Imano, Tatsuki Itoh, Takao Satou, et al.
Toxicology and Applied Pharmacology|July 16, 2016
Mangiferin, a novel nuclear factor kappa B-inducing kinase inhibitor, suppresses metastasis and tumor growth in a mouse metastatic melanoma modelTomoya Takeda, Masanobu Tsubaki, Kotaro Sakamoto, et al.
Cell Biology International|July 15, 2009
Dimethylfumarate inhibits tumor cell invasion and metastasis by suppressing the expression and activities of matrix metalloproteinases in melanoma cellsYuzuru Yamazoe, Masanobu Tsubaki, Hiroshi Matsuoka, et al.
Leukemia Research|November 19, 2013
By inhibiting Src, verapamil and dasatinib overcome multidrug resistance via increased expression of Bim and decreased expressions of MDR1 and survivin in human multidrug-resistant myeloma cellsMasanobu Tsubaki, Makiko Komai, Tatsuki Itoh, et al.
Journal of Biomedical Science|February 5, 2014
Nitrogen-containing bisphosphonates inhibit RANKL- and M-CSF-induced osteoclast formation through the inhibition of ERK1/2 and Akt activationMasanobu Tsubaki, Makiko Komai, Tatsuki Itoh, et al.
Journal of Bone Oncology|September 9, 2017
Increased risk of SSEs in bone-only metastatic breast cancer patients treated with zoledronic acidMasashi Yanae, Shinichiro Fujimoto, Kaori Tane, et al.
International Journal of Cancer|November 29, 2014
PKC/MEK inhibitors suppress oxaliplatin-induced neuropathy and potentiate the antitumor effectsMasanobu Tsubaki, Tomoya Takeda, Tadahumi Tani, et al.
Scientific Reports|January 9, 2016
PKN3 is the major regulator of angiogenesis and tumor metastasis in miceHideyuki Mukai, Aiko Muramatsu, Rana Mashud, et al.
European Journal of Cancer (Oxford, England : 1990)|August 13, 2013
Inhibition of the tumour necrosis factor-alpha autocrine loop enhances the sensitivity of multiple myeloma cells to anticancer drugsMasanobu Tsubaki, Makiko Komai, Tatsuki Itoh, et al.
Targeted Oncology|July 4, 2012
Peritoneal metastatic lesions of gastric cancer exhibit low expression of human epidermal growth factor receptor 2Motohiro Imano, Takao Satou, Tatsuki Itoh, et al.
Pageof 13

Showing results (111-120 of 126) with videos related to

Sort By:
Pageof 13
Anticancer Research|April 9, 2013
Establishment of a novel model of peritoneal carcinomatosis of the peritoneal extension typeMotohiro Imano, Tatsuki Itoh, Takao Satou, et al.
Toxicology and Applied Pharmacology|July 16, 2016
Mangiferin, a novel nuclear factor kappa B-inducing kinase inhibitor, suppresses metastasis and tumor growth in a mouse metastatic melanoma modelTomoya Takeda, Masanobu Tsubaki, Kotaro Sakamoto, et al.
Cell Biology International|July 15, 2009
Dimethylfumarate inhibits tumor cell invasion and metastasis by suppressing the expression and activities of matrix metalloproteinases in melanoma cellsYuzuru Yamazoe, Masanobu Tsubaki, Hiroshi Matsuoka, et al.
Leukemia Research|November 19, 2013
By inhibiting Src, verapamil and dasatinib overcome multidrug resistance via increased expression of Bim and decreased expressions of MDR1 and survivin in human multidrug-resistant myeloma cellsMasanobu Tsubaki, Makiko Komai, Tatsuki Itoh, et al.
Journal of Biomedical Science|February 5, 2014
Nitrogen-containing bisphosphonates inhibit RANKL- and M-CSF-induced osteoclast formation through the inhibition of ERK1/2 and Akt activationMasanobu Tsubaki, Makiko Komai, Tatsuki Itoh, et al.
Journal of Bone Oncology|September 9, 2017
Increased risk of SSEs in bone-only metastatic breast cancer patients treated with zoledronic acidMasashi Yanae, Shinichiro Fujimoto, Kaori Tane, et al.
International Journal of Cancer|November 29, 2014
PKC/MEK inhibitors suppress oxaliplatin-induced neuropathy and potentiate the antitumor effectsMasanobu Tsubaki, Tomoya Takeda, Tadahumi Tani, et al.
Scientific Reports|January 9, 2016
PKN3 is the major regulator of angiogenesis and tumor metastasis in miceHideyuki Mukai, Aiko Muramatsu, Rana Mashud, et al.
European Journal of Cancer (Oxford, England : 1990)|August 13, 2013
Inhibition of the tumour necrosis factor-alpha autocrine loop enhances the sensitivity of multiple myeloma cells to anticancer drugsMasanobu Tsubaki, Makiko Komai, Tatsuki Itoh, et al.
Targeted Oncology|July 4, 2012
Peritoneal metastatic lesions of gastric cancer exhibit low expression of human epidermal growth factor receptor 2Motohiro Imano, Takao Satou, Tatsuki Itoh, et al.
Pageof 13